Concepedia

Publication | Closed Access

Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia

126

Citations

31

References

2011

Year

Abstract

Tifacogin showed no mortality benefit in patients with sCAP despite evidence of biologic activity.

References

YearCitations

Page 1